Market Tracker

05/24 5:38am ET

Arbutus Biopharma Corp (NASDAQ:ABUS)

4.03
Delayed Data
As of May 23
 -0.05 / -1.23%
Today’s Change
2.72
Today|||52-Week Range
15.63
-9.44%
Year-to-Date
No recent news for Arbutus Biopharma Corp.

Today’s Trading

Previous close4.08
Today’s open4.08
Day’s range3.98 - 4.17
Volume89,687
Average volume (3 months)204,019
Market cap$222.9M
Dividend yield--
Data as of 05/23/2016

Growth & Valuation

Earnings growth (last year)+25.56%
Earnings growth (this year)-10.88%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+66.34%
P/E ratio--
Price/Sales8.13
Price/Book0.41

Competitors

 Today’s
change
Today’s
% change
FLKSFlex Pharma Inc-0.24-1.93%
CMRXChimerix Inc+0.02+0.42%
PETXAratana Therapeutics...+0.10+1.62%
VTAEVitae Pharmaceutical...+0.76+9.57%
Data as of 05/23/2016

Financials

Next reporting dateAugust 11, 2016
EPS forecast (this quarter)-$0.39
Annual revenue (last year)$24.9M
Annual profit (last year)-$61.1M
Net profit margin-245.73%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Murray
Chief Financial Officer &
Executive Vice President
Bruce G. Cousins
Corporate headquarters
Burnaby, British Columbia

Forecasts